Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 September 2018

September 7, 2018 – At its monthly meeting, the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) did not start or conclude a new referral. More information on all safety reviews currently under evaluation is provided in the table below. The Committee elected Dr Martin Huber from Germany as the new vice-chair to take over from Dr Álmath Spooner. Dr Spooner has served for two three-year mandates, the maximum allowed … (leggi tutto)